Literature DB >> 9354587

The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation.

L M Vervoort1, J E Ronden, H H Thijssen.   

Abstract

In the vitamin K cycle, vitamin K-hydroquinone, the active cofactor for gamma-glutamylcarboxylase, is continuously regenerated. The successive pathways contain oxidation of the hydroquinone to the epoxide, followed by reduction to the quinone and reduction to the hydroquinone. Vitamin K-hydroquinone is a potent radical scavenging species (Mukai et al., J Biol Chem 267: 22277-22281, 1992). We tested the potential antioxidant activity of the vitamin K cycle in lipid peroxidation reactions (thiobarbituric acid reactive substances, TBARS) in rat liver microsomes. As prooxidant we used Fe2+/ascorbate, NADPH-Fe3+/ATP, and NADPH/CCl4. Vitamin K (< or = 50 microM) on its own did not influence the formation of TBARS. In combination with 1 mM dithiothreitol (DTT), the reductive cofactor for the microsomal enzyme vitamin K epoxide reductase, vitamin K suppressed lipid peroxidation with a concentration that blocked the maximal response by 50% (IC50) of ca. 0.2 microM. Vitamin K1 (phylloquinone) and vitamin K2 (menaquinone-4) were equally active. Warfarin (5 microM) and chloro-vitamin K (50 microM), inhibitors of vitamin K epoxide reductase and gamma-glutamylcarboxylase, respectively, were able to completely abolish the antioxidant effect. Lipid peroxidation was inversely related to the amount of vitamin K hydroquinone in the reaction. Vitamin K epoxide reductase seemed sensitive to lipid peroxidation, with half of the activity being lost within 10 min during oxidation with NADPH/CCl4. The inactivation could be attenuated by antioxidants such as vitamin E, reduced glutathione, and menadione and also by a K vitamin in combination with DTT, but not by superoxide dismutase and catalase. The results show that the vitamin K cycle could act as a potent antioxidant, that the active species in all probability is vitamin K-hydroquinone, and that the primary reaction product is the semiquinone. The results also show that the reaction product is processed in the vitamin K cycle to regenerate vitamin K-hydroquinone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354587     DOI: 10.1016/s0006-2952(97)00254-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  23 in total

1.  Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger?

Authors:  Petal A Wijnen; Johny A Verschakelen; Aalt Bast; Otto Bekers; Marjolein Drent
Journal:  Lung       Date:  2012-11-13       Impact factor: 2.584

2.  Human vitamin K 2,3-epoxide reductase complex subunit 1-like 1 (VKORC1L1) mediates vitamin K-dependent intracellular antioxidant function.

Authors:  Philipp Westhofen; Matthias Watzka; Milka Marinova; Moritz Hass; Gregor Kirfel; Jens Müller; Carville G Bevans; Clemens R Müller; Johannes Oldenburg
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

Review 3.  Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis.

Authors:  Martin J Shearer; Paul Newman
Journal:  J Lipid Res       Date:  2014-01-31       Impact factor: 5.922

4.  Effect of 1-year dietary supplementation with vitaminized olive oil on markers of bone turnover and oxidative stress in healthy post-menopausal women.

Authors:  Laura Mazzanti; Maurizio Battino; Laura Nanetti; Francesca Raffaelli; Alessandro Alidori; Giulia Sforza; Flavia Carle; Veronica Quagliarini; Nelvio Cester; Arianna Vignini
Journal:  Endocrine       Date:  2015-01-20       Impact factor: 3.633

5.  Vitamin K1 inhibits ferroptosis and counteracts a detrimental effect of phenprocoumon in experimental acute kidney injury.

Authors:  Benedikt Kolbrink; Friedrich Alexander von Samson-Himmelstjerna; Maja Lucia Messtorff; Theresa Riebeling; Raphael Nische; Jessica Schmitz; Jan Hinrich Bräsen; Ulrich Kunzendorf; Stefan Krautwald
Journal:  Cell Mol Life Sci       Date:  2022-06-28       Impact factor: 9.207

6.  Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.

Authors:  Noriko Koitaya; Mariko Sekiguchi; Yuko Tousen; Yoriko Nishide; Akemi Morita; Jun Yamauchi; Yuko Gando; Motohiko Miyachi; Mami Aoki; Miho Komatsu; Fumiko Watanabe; Koji Morishita; Yoshiko Ishimi
Journal:  J Bone Miner Metab       Date:  2013-05-24       Impact factor: 2.626

7.  Suppression of UVC-induced cell damage and enhancement of DNA repair by the fermented milk, Kefir.

Authors:  Tsutomu Nagira; Junko Narisawa; Kiichirou Teruya; Yoshinori Katakura; Sun-Yup Shim; Ken-Ichi Kusumoto; Sennosuke Tokumaru; Koichiro Tokumaru; David W Barnes; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2002-11       Impact factor: 2.058

8.  Proteomic Charting of Imipenem Adaptive Responses in a Highly Carbapenem Resistant Clinical Enterobacter roggenkampii Isolate.

Authors:  Suruchi Nepal; Sandra Maaß; Stefano Grasso; Francis M Cavallo; Jürgen Bartel; Dörte Becher; Erik Bathoorn; Jan Maarten van Dijl
Journal:  Antibiotics (Basel)       Date:  2021-04-28

9.  The Integrity of Heme Is Essential for Reproducible Detection of Metronidazole-Resistant Clostridioides difficile by Agar Dilution Susceptibility Tests.

Authors:  Xiaoqian Wu; Wan-Jou Shen; Aditi Deshpande; Abiola O Olaitan; Kelli L Palmer; Kevin W Garey; Julian G Hurdle
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

10.  A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle.

Authors:  Xuejie Chen; Caihong Li; Da-Yun Jin; Brian Ingram; Zhenyu Hao; Xue Bai; Darrel W Stafford; Keping Hu; Jian-Ke Tie
Journal:  Blood       Date:  2020-08-13       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.